Cercle AI Secures $6 Million in Seed Funding to Revolutionize Women's Healthcare with AI Technology

Cercle AI, a pioneering technology company dedicated to advancing healthcare for women, proudly announces the successful raising of $6,000,000 in funding to further fuel its mission. By harnessing the power of AI and transforming vast amounts of anonymized, diverse biomedical and genomics data into actionable insights, Cercle aims to revolutionize women’s health, an area often overlooked in the broader healthcare landscape. With this funding, the company is set to enhance its groundbreaking Cercle™ Biomedical Graph—an innovative knowledge graph that securely analyzes billions of data points from hospitals, clinics, and research labs worldwide. This will empower healthcare providers, from doctors to pharmaceutical companies, with unprecedented levels of clarity and insight, thereby improving patient care and treatment outcomes. Initially focusing on fertility and IVF, Cercle is thrilled to beta launch its first product, Luce, a fertility companion designed to assist women and their healthcare providers in making informed decisions throughout their fertility journeys. Additionally, the funding will support Cercle’s comprehensive suite of products, including data access tools for researchers, advanced modeling solutions for healthcare providers, and personalized patient insights, all developed by a passionate team of medical professionals, molecular biologists, data scientists, engineers, and entrepreneurs. By fostering innovation and supporting healthcare advancements, Cercle is committed to creating a world where women feel empowered and informed about their health, ensuring their unique healthcare needs are met with the utmost care and expertise.